Rizatriptan Tablet, Film Coated
Product Images NDC 71335-1352

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan (NDC 71335-1352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This is a graph showing the estimated probability of response to treatment with placebo or different doses of Rizatriptan Benzoate Tablets (5mg and 10mg) over time, measured in hours post-dose.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
The text is describing the estimated probability of remedication or rescue after taking different types of tablets, including a placebo and Rizatriptan Benzoate Tablets in 5 mg and 10 mg doses at various time intervals post-dose.*
FDA Label Image

Label Image (Lbl713351352)

Label Image (Lbl713351352)
This is a medicine package for Rizatriptan, a drug used to treat migraines. It contains pink capsules each with 10mg of Benzoate. The package consists of two tablets stored at room temperature (20°-25°C/68°-77°F) and should be kept away from children. The manufacturer is Macleods Pharmaceuticals Ltd. The package has an expiration date of MM/YY and an NDC 7133513521 07433101523487.*
FDA Label Image

Fig-5 (Rizatriptan Fct Figure 5)

Fig-5 (Rizatriptan Fct Figure 5)
This is a graph or chart showing the effectiveness of Ruzatriptan Benzoate Orally Disintegrating Tablets compared to a placebo. The X-axis measures time in hours after taking the Stage 2 dose, and the Y-axis measures effectiveness on a scale from 0 to 20.*
FDA Label Image

Rizatriptan-structure (Structure1)

Rizatriptan-structure (Structure1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.